UnknownNot Applicable

Pilot Study On Pulsed Electromagnetic Field Therapy For Osteosarcopenia

Singapore80 participantsStarted 2021-10-01

Plain-language summary

This prospective, single-site, single arm pilot study aims to assess the efficacy of Pulsed Electromagnetic Field (PEMF) exposure in the reduction of the decline in muscle strength, function and bone mineral density (BMD) in osteosarcopenia.

Who can participate

Age range65 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 65 years old and above, which corresponds to the geriatric patient population seen at the Healthy Ageing clinics and wards
✓. Diagnosed with primary osteopenia, including primary osteoporosis, by BMD measurements on DEXA scans
✓. Diagnosed with sarcopenia by SARC-F
✓. Willing and able to give written informed consent

Exclusion criteria

✕. Presence of metallic implants, pacemakers or insulin pumps
✕. Presence of rheumatological disease (such as osteoarthritis or rheumatoid arthritis)
✕. Presence of secondary osteoporosis (such as hyperparathyroidism, steroid-induced osteoporosis)
✕. Presence of end-stage organ failure, including severe dementia or cancer
✕. Pregnant women

What they're measuring

Lower limb strength

Timeframe: 18 weeks

Handgrip strength

Timeframe: 18 weeks

Short Physical Performance Battery (SPPB)

Timeframe: 18 weeks

6 minute walk test (6MWT)

Timeframe: 18 weeks

Trial details

NCT IDNCT05043480

SponsorLouis Tee

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

Contact for this trial

Santhosh Seetharaman, MBBS

90302683 mdcsnks@nus.edu.sg

View on ClinicalTrials.gov More Sarcopenia trials